SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACMI - Accumed Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sigmund who wrote (709)12/18/1997 10:45:00 AM
From: Cisco  Read Replies (1) of 1894
 
Sigmund,

You bring up the point of poor reimbursement rate for the pap smear test. I believe that the laboratories are going to have to shoulder more of the responsibility for the poor reimbursement.

Laboratories have been using the Pap Smear testing as a cost leader to get professionals to use their other services. Insurance companies based their reimbursement upon a percentage of the usual and customary fee. For example I believe Medicare will be paying 74% of the median charge for laboratory services in 1998. I believe this represents a 2% reduction from this year.¯

Where do the insurance companies get their usual and customary or median fee? From past billing history of course. Therefore, I would like to suggest that the laboratories took a calculated risk and ended up cutting their own throat. It will take time and improve billing practices on the part of laboratories before we see marked improvement in reimbursement in this cost cutting managed care environment.

Also, it should be understood that just because an insurance company says they will pay for a certian procedure, it doesn't mean the reimbursement rate will be high enough to cover the cost of the procedure.

This is exactly what gives AccuMed its advantage. Here is a quote from CAP Today's June 1997 Sidebar on three approaches to improved screening:

®Dr. Pressman says that one fundamental difference between AccuMed's products and other technologies is that AccuMed's are intended to reduce overall cost. "They actually save the laboratory money through labor cost saving," he asserts.

Cisco
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News